UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2015-11, Vol.13 (11), p.2119-2126

2015

Volltextzugriff (PDF)

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.875-885

2016

Volltextzugriff (PDF)

Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series

Journal of thrombosis and haemostasis, 2011-12, Vol.9 (12), p.2389-2396

2011

Volltextzugriff (PDF)

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Journal of thrombosis and haemostasis, 2014-04, Vol.12 (4), p.479-487

2014

Volltextzugriff (PDF)

Perioperative Bridging Anticoagulation in Patients With Atrial Fibrillation

Journal of vascular surgery, 2016, Vol.63 (1), p.281-281

2016

Volltextzugriff (PDF)

PCV38 Venous Thromboembolism: A Refined United States Cost Model with Long Term Attack Rates

Value in health, 2012-06, Vol.15 (4), p.A118-A118

2012

Volltextzugriff (PDF)

Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion

Thrombosis research, 2013-04, Vol.131 (4), p.300-303

2013

Volltextzugriff (PDF)

Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: A pediatric experience

Thrombosis research, 2012-10, Vol.130 (4), p.612-615

2012

Volltextzugriff (PDF)

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1028-1035

2015

Volltextzugriff (PDF)

Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung

Thrombosis research, 2012-04, Vol.129, p.S188-S189

2012

Volltextzugriff (PDF)

Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy

Thrombosis research, 2012-04, Vol.129, p.S182-S182

2012

Volltextzugriff (PDF)

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2556-2559

2016

Volltextzugriff (PDF)

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.692-694

2012

Volltextzugriff (PDF)

Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)

Journal of thrombosis and haemostasis, 2007-11, Vol.5 (11), p.2211-2218

2007

Volltextzugriff (PDF)

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings

Journal of thrombosis and haemostasis, 2015-09, Vol.13 (9), p.1597-1605

2015

Volltextzugriff (PDF)

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1246-1252

2006

Volltextzugriff (PDF)

Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients

Journal of thrombosis and haemostasis, 2009-06, Vol.7 (6), p.1041-1042

SPYROPOULOS, A. C.

2009

Volltextzugriff (PDF)

Ovarian cancer and venous thromboembolic risk

Gynecologic oncology, 2005-10, Vol.99 (1), p.119-125

2005

Volltextzugriff (PDF)

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1443-1448

2013

Volltextzugriff (PDF)

Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1593-1596

2013

Volltextzugriff (PDF)

First External Validation of the New COMPASS-CAT Risk Assessment Model for Ambulatory Patients with Breast, Colorectal, Lung or Ovarian Cancer

Thrombosis research, 2018-04, Vol.164, p.S232-S232

2018

Volltextzugriff (PDF)

Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?

Journal of thrombosis and haemostasis, 2010-03, Vol.8 (3), p.496-498

2010

Volltextzugriff (PDF)

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2621-2624

2012

Volltextzugriff (PDF)

PO-73 Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung

Thrombosis research, 2012-04, Vol.129, p.S188-S189

2012

Volltextzugriff (PDF)

PO-54 Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy

Thrombosis research, 2012-04, Vol.129, p.S182-S182

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Cardiovascular System & Cardiology
(15)
Hematology
(15)
Peripheral Vascular Disease
(14)
Female
(12)
Male
(11)
Aged
(9)
Administration, Oral
(8)
Anticoagulants - Therapeutic Use
(8)
Anticoagulants - Administration & Dosage
(7)
Risk Factors
(7)
Anticoagulants - Adverse Effects
(6)
Time Factors
(6)
Hemorrhage - Chemically Induced
(5)
Middle Aged
(5)
Treatment Outcome
(5)
Anticoagulants
(4)
Atrial Fibrillation - Complications
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery

Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial

Perioperative Bridging Anticoagulation in Patients With Atrial Fibrillation

PCV38 Venous Thromboembolism: A Refined United States Cost Model with Long Term Attack Rates

Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion

Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: A pediatric experience

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung

Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy

Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry

Upper vs. lower extremity deep vein thrombosis: outcome definitions of venous thromboembolism for clinical predictor rules or risk factor analyses in hospitalized patients

Ovarian cancer and venous thromboembolic risk

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach

Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH

First External Validation of the New COMPASS-CAT Risk Assessment Model for Ambulatory Patients with Breast, Colorectal, Lung or Ovarian Cancer

Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

PO-73 Impact of lobectomy on hypercoagulable state in patients with primary adenocarcinoma of the lung

PO-54 Variability of response of thromboprophylaxis with fixed dose of enoxaparin in patients with primary adenocarcinoma of the lung undergoing lobectomy

Suchergebnisse filtern